GS
GILD icon

GWN Securities’s Gilead Sciences GILD Stock Holding History

GWN Securities’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.28M Buy
10,108
+20
+0.2% +$2.63K 0.21% 126
2026
Q1 		$1.41M Sell
10,088
-595
-6% -$83.3K 0.27% 97
2025
Q4 		$1.31M Buy
10,683
+1,675
+19% +$204K 0.27% 97
2025
Q3 		$1.01M Buy
9,008
+1,129
+14% +$128K 0.23% 106
2025
Q2 		$883K Sell
7,879
-12,622
-62% -$1.34M 0.16% 132
2025
Q1 		$2.1M Buy
20,501
+17,425
+566% +$1.8M 0.12% 190
2024
Q4 		$285K Buy
+3,076
New +$277K 0.08% 257

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GWN Securities's GILD Position: Q2 2026 in Review

GWN Securities increased its Gilead Sciences (GILD) stake by 0.2% in Q2 2026, buying an estimated $2.63K and bringing the position to 10,108 shares worth $1.28M. The position accounts for 0.21% of the portfolio, ranked #126.

GWN Securities first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.1M in Q1 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • GWN Securities held 10,108 shares of Gilead Sciences worth $1.28M as of Q2 2026.
  • GWN Securities bought 20 Gilead Sciences shares in Q2 2026, an estimated $2.63K.
  • Gilead Sciences made up 0.21% of GWN Securities's portfolio in Q2 2026, its #126 holding.
  • GWN Securities first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • GWN Securities's Gilead Sciences position peaked at $2.1M in Q1 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on GWN Securities's 13F filing for Q2 2026, filed 5 Aug 2026.